Hello,
I've recently started to work with gene editing using CRISPR/cas9 and I was wondering something that I never see mentioned on papers like this. How to evaluate the gene editing efficiency and the "zigosity" of your target editing? Especially when performing knock-ins.
For example, the cells HEK293 are commonly used in this type of assays and are hypotriploid, in accordance with ATCC.
I ask because I want to start to try performing knock-ins and my candidate cells lines are the HT-29 (also hypertriploid). I wonder if I could have the edition in a set of chromosomes, but not in the others.
If anyone knows something about it, I'll be happy to hear it.
Thanks!